Thyrocare Technologies Limited announced at the board meeting held on January 28, 2022, the directors approved appointment of Mr. Sachin Salvi, presently working as Senior Vice-President-Finance, as Chief Financial Officer of the Company effective from 28th January 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
628 INR | -0.62% |
|
-1.70% | -2.56% |
05-14 | Transcript : Thyrocare Technologies Limited, Q4 2024 Earnings Call, May 14, 2024 | |
05-14 | Thyrocare Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.56% | 401M | |
-18.17% | 8.53B | |
+65.89% | 4.26B | |
+6.50% | 2.71B | |
-2.28% | 2.63B | |
-57.14% | 1.72B | |
-19.16% | 1.67B | |
-20.01% | 1.45B | |
+15.38% | 1.19B | |
-50.40% | 1.01B |
- Stock Market
- Equities
- THYROCARE Stock
- News Thyrocare Technologies Limited
- Thyrocare Technologies Limited Appoints Sachin Salvi as Chief Financial Officer